ginsenoside rh2 has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Guo, XH; Li, W; Yang, L; Yu, T; Zou, L | 1 |
| Feng, H; Hu, R; Li, M; Wu, GC; Wu, N | 1 |
| Kim, HE; Lee, SK; Oh, JH; Oh, YJ | 1 |
3 other study(ies) available for ginsenoside rh2 and Glioma
| Article | Year |
|---|---|
[Preparation and characterization of ginsenoside-Rhâ‚‚ lipid nanoparticles and synergistic effect with borneol in resisting tumor activity].
Topics: Antineoplastic Agents; Camphanes; Cell Line, Tumor; Drug Carriers; Drug Synergism; Ginsenosides; Glioma; Humans; Lipids; Nanoparticles; Particle Size | 2016 |
Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128.
Topics: Antineoplastic Agents; Cell Proliferation; Ginsenosides; Glioma; Humans; MicroRNAs; Molecular Targeted Therapy; Panax; Phytotherapy; Plant Extracts; Plants, Medicinal; Up-Regulation | 2011 |
Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspases; DNA Fragmentation; Enzyme Activation; Ginsenosides; Glioma; Immunoblotting; Oxidative Stress; Panax; Plants, Medicinal; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Saponins; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured | 1999 |